Construction method of model for predicting curative effect of PD-1
The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is n...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ZHENG LIMOU HU JING YANG SHUANG ZHENG FANGKE |
description | The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is not subjected to other treatments during the period; 2) after the patient is subjected to PD-1/PD-L1treatment, performing CT scanning every three months; 3) performing conventional RNA-seq sequencing on the sample; (4) analyzing RNA-seq biological information; 5) constructing and screening RNA-seq data characteristics for predicting the curative effect of the PD-1; and 6) constructing the model for predicting the curative effect of the PD-1. Compared with a conventional PD-1 curative effect prediction molecular marker , an RNA sequencing molecular marker is more accurate in prediction result, and lower in cost.
本发明公开了一种用于预测PD-1疗效的模型的构建方法,包括如下步骤:1)选取用药时间前一个月内穿刺或石蜡组织的样本的RNA-seq作为基线,患者在此期间内未接受其他治疗;2)患者进行PD-1/PD-L1治疗后,每 |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN111883203A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN111883203A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN111883203A3</originalsourceid><addsrcrecordid>eNrjZHB2zs8rLikqTS7JzM9TyE0tychPUchPU8jNT0nNUUjLL1IoKEpNyQRK56UrJJcWJZZklqUqpKalpSaXgNQFuOga8jCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_Q0NDCwtjIwNjR2Ni1AAATIExuQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Construction method of model for predicting curative effect of PD-1</title><source>esp@cenet</source><creator>ZHENG LIMOU ; HU JING ; YANG SHUANG ; ZHENG FANGKE</creator><creatorcontrib>ZHENG LIMOU ; HU JING ; YANG SHUANG ; ZHENG FANGKE</creatorcontrib><description>The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is not subjected to other treatments during the period; 2) after the patient is subjected to PD-1/PD-L1treatment, performing CT scanning every three months; 3) performing conventional RNA-seq sequencing on the sample; (4) analyzing RNA-seq biological information; 5) constructing and screening RNA-seq data characteristics for predicting the curative effect of the PD-1; and 6) constructing the model for predicting the curative effect of the PD-1. Compared with a conventional PD-1 curative effect prediction molecular marker , an RNA sequencing molecular marker is more accurate in prediction result, and lower in cost.
本发明公开了一种用于预测PD-1疗效的模型的构建方法,包括如下步骤:1)选取用药时间前一个月内穿刺或石蜡组织的样本的RNA-seq作为基线,患者在此期间内未接受其他治疗;2)患者进行PD-1/PD-L1治疗后,每</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PHYSICS ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201103&DB=EPODOC&CC=CN&NR=111883203A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201103&DB=EPODOC&CC=CN&NR=111883203A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHENG LIMOU</creatorcontrib><creatorcontrib>HU JING</creatorcontrib><creatorcontrib>YANG SHUANG</creatorcontrib><creatorcontrib>ZHENG FANGKE</creatorcontrib><title>Construction method of model for predicting curative effect of PD-1</title><description>The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is not subjected to other treatments during the period; 2) after the patient is subjected to PD-1/PD-L1treatment, performing CT scanning every three months; 3) performing conventional RNA-seq sequencing on the sample; (4) analyzing RNA-seq biological information; 5) constructing and screening RNA-seq data characteristics for predicting the curative effect of the PD-1; and 6) constructing the model for predicting the curative effect of the PD-1. Compared with a conventional PD-1 curative effect prediction molecular marker , an RNA sequencing molecular marker is more accurate in prediction result, and lower in cost.
本发明公开了一种用于预测PD-1疗效的模型的构建方法,包括如下步骤:1)选取用药时间前一个月内穿刺或石蜡组织的样本的RNA-seq作为基线,患者在此期间内未接受其他治疗;2)患者进行PD-1/PD-L1治疗后,每</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PHYSICS</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB2zs8rLikqTS7JzM9TyE0tychPUchPU8jNT0nNUUjLL1IoKEpNyQRK56UrJJcWJZZklqUqpKalpSaXgNQFuOga8jCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_Q0NDCwtjIwNjR2Ni1AAATIExuQ</recordid><startdate>20201103</startdate><enddate>20201103</enddate><creator>ZHENG LIMOU</creator><creator>HU JING</creator><creator>YANG SHUANG</creator><creator>ZHENG FANGKE</creator><scope>EVB</scope></search><sort><creationdate>20201103</creationdate><title>Construction method of model for predicting curative effect of PD-1</title><author>ZHENG LIMOU ; HU JING ; YANG SHUANG ; ZHENG FANGKE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN111883203A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PHYSICS</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHENG LIMOU</creatorcontrib><creatorcontrib>HU JING</creatorcontrib><creatorcontrib>YANG SHUANG</creatorcontrib><creatorcontrib>ZHENG FANGKE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHENG LIMOU</au><au>HU JING</au><au>YANG SHUANG</au><au>ZHENG FANGKE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Construction method of model for predicting curative effect of PD-1</title><date>2020-11-03</date><risdate>2020</risdate><abstract>The invention discloses a construction method of a model for predicting the curative effect of PD1. The construction method comprises the following steps of 1) selecting RNA-seq of a puncture or paraffin tissue sample within one month before medication as a baseline, and ensuring that a patient is not subjected to other treatments during the period; 2) after the patient is subjected to PD-1/PD-L1treatment, performing CT scanning every three months; 3) performing conventional RNA-seq sequencing on the sample; (4) analyzing RNA-seq biological information; 5) constructing and screening RNA-seq data characteristics for predicting the curative effect of the PD-1; and 6) constructing the model for predicting the curative effect of the PD-1. Compared with a conventional PD-1 curative effect prediction molecular marker , an RNA sequencing molecular marker is more accurate in prediction result, and lower in cost.
本发明公开了一种用于预测PD-1疗效的模型的构建方法,包括如下步骤:1)选取用药时间前一个月内穿刺或石蜡组织的样本的RNA-seq作为基线,患者在此期间内未接受其他治疗;2)患者进行PD-1/PD-L1治疗后,每</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_CN111883203A |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE |
title | Construction method of model for predicting curative effect of PD-1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A36%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHENG%20LIMOU&rft.date=2020-11-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN111883203A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |